AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (August 5, 2008). doi:10.1152/ajpendo.90438.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/4/E884    most recent
90438.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Radenne, A.
Right arrow Articles by Mounier, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radenne, A.
Right arrow Articles by Mounier, C.
Submitted on May 13, 2008
Revised on July 15, 2008
Accepted on July 18, 2008

HEPATIC REGULATION OF FATTY ACID SYNTHASE BY INSULIN AND T3: EVIDENCE FOR T3 GENOMIC AND NON-GENOMIC ACTIONS

Anne Radenne1, Murielle Akpa1, Caroline Martel1, Sabine Sawadogo1, Daniel Mauvoisin2, and Catherine Mounier1*

1 Université du Québec à montréal
2 Université du Québec à Montréal

* To whom correspondence should be addressed. E-mail: mounier.catherine{at}uqam.ca.

Fatty acid synthase (FAS) is a key enzyme of hepatic lipogenesis responsible for the synthesis of long chain saturated fatty acids. This enzyme is mainly regulated at the transcriptional level by nutrients and hormones. In particular, glucose, insulin and T3 increase FAS activity whereas glucagon, saturated and polyunsaturated fatty acids decrease it. In the present study, we show that, in liver, T3 and insulin were able to activate FAS enzymatic activity, mRNA expression and gene transcription. We have localized the T3 response element (TRE) that mediates the T3 genomic effect, on the FAS promoter between -741 and -696 bp that mediates the T3 genomic effect. We show that both T3 and insulin regulate FAS transcription via this sequence. The TRE binds a TR/RXR heterodimer, even in the absence of hormone and this binding is increased in response to T3 and/or insulin treatment. The use of H7, a serine/threonine kinase inhibitor, reveals that a phosphorylation mechanism is implicated in the transcriptional regulation of FAS in response to both hormones. Specifically, we show that T3 is able to modulate FAS transcription via a non-genomic action targeting the TRE through the activation of a PI3-kinase-Erk1/2-MAPK dependent pathway. Insulin also targets the TRE sequence, probably via the activation of two parallel pathways: Ras/Erk1/2 MAPK and PI3-kinase/Akt. Finally, our data suggest that the non-genomic actions of T3 and insulin are probably common to several TREs, as we observed similar effects on a classical DR4 consensus sequence.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.